in this issue
People & Business :: Earnings/Finance
Lenzing says difficult market in first quarter; sales fall 9%, Ebitda plunges 30%
10:20 AM MDT | May 16, 2014 | Michael Ravenscroft
Lenzing (Lenzing, Austria) says that sales in first-quarter 2014 were €451.7 million ($618.8 million), compared with €496.5 million in the corresponding quarter a year ago, a decrease of 9%. Ebitda fell to €46.3 million, versus €66.3 million in first-quarter 2013, a decrease of 30% year-on-year (YOY). Ebitda margin fell to 10.2% in first-quarter 2014, compared with 13.4% a year ago. First-quarter 2014 Ebit plunged 52% to €16.7 million, versus €35.1 million in the year-ago period. First quarter 2014 was marked by continuous erosion of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee